Excitatory Amino Acids Contribute to the Pathogenesis of Perinatal Hypoxic-Ischemic Brain Injury
dc.contributor.author | Barks, John D. E. | en_US |
dc.contributor.author | Silverstein, Faye Sarah | en_US |
dc.date.accessioned | 2010-06-01T22:31:41Z | |
dc.date.available | 2010-06-01T22:31:41Z | |
dc.date.issued | 1992-07 | en_US |
dc.identifier.citation | Barks, John D.E.; Silverstein, Faye S. (1992). "Excitatory Amino Acids Contribute to the Pathogenesis of Perinatal Hypoxic-Ischemic Brain Injury." Brain Pathology 2(3): 235-243. <http://hdl.handle.net/2027.42/75512> | en_US |
dc.identifier.issn | 1015-6305 | en_US |
dc.identifier.issn | 1750-3639 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75512 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1343839&dopt=citation | en_US |
dc.format.extent | 1135447 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1992 The International Society of Neuropathology | en_US |
dc.title | Excitatory Amino Acids Contribute to the Pathogenesis of Perinatal Hypoxic-Ischemic Brain Injury | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-0570, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, MI 48109-0570, U.S.A. | en_US |
dc.identifier.pmid | 1343839 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75512/1/j.1750-3639.1992.tb00697.x.pdf | |
dc.identifier.doi | 10.1111/j.1750-3639.1992.tb00697.x | en_US |
dc.identifier.source | Brain Pathology | en_US |
dc.identifier.citedreference | Choi DW, Rothman SM ( 1990 ) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13: 171 – 182. | en_US |
dc.identifier.citedreference | Jorgensen MB, Diemer NH ( 1982 ) Selective neuron loss after cerebral ischemia in the rat: Possible role of transmitter glutamate. Acta Neurol Scand 66: 536 – 46. | en_US |
dc.identifier.citedreference | Simon RR Swan JH, Griffiths T., Meldrum BS ( 1984 ) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850 – 852. | en_US |
dc.identifier.citedreference | Wieloch T., Lindvall O., Blomqvist P., Gage F. ( 1984 ) Evidence for amelioration of ischemic neuronal damage in the hippocampal formation by lesions of the perforant path. Neurol Res 7: 24 – 26. | en_US |
dc.identifier.citedreference | Benveniste H., Drejer J., Schousboe A., Diemer NH ( 1984 ) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43: 1369 – 1374. | en_US |
dc.identifier.citedreference | Hagberg H., Andersson P., Kjellmer I., Thiringer K., Thordstein M. ( 1987 ) Extracellular overflow of glutamate, aspartate, GABA, and taurine in cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci Lett 768: 311 – 317. | en_US |
dc.identifier.citedreference | McDonald JW, Silverstein FS, Johnston MV ( 1987 ) MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 140: 359 – 361. | en_US |
dc.identifier.citedreference | Choi DW ( 1990 ) Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 2: 105 – 147. | en_US |
dc.identifier.citedreference | Choi DW ( 1990 ) Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 10: 2493 – 2501. | en_US |
dc.identifier.citedreference | Watkins JC, Krogsgaard-Larsen P., Honore T. ( 1990 ) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci 11: 25 – 33. | en_US |
dc.identifier.citedreference | Lodge D., Johnson KM ( 1990 ) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11: 81 – 86. | en_US |
dc.identifier.citedreference | Young AB, Fagg GE ( 1990 ) Excitatory amino acid receptors in the brain: Membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci 11: 126 – 133. | en_US |
dc.identifier.citedreference | Reynolds IJ, Miller RJ ( 1990 ) Allosteric modulation of N-methyl-D-aspartate receptors. Adv Pharmacol 21: 101 – 126. | en_US |
dc.identifier.citedreference | Williams K., Hanna JL, Molinoff PB ( 1991 ) Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mo/ Pharmacol 40: 774 – 782. | en_US |
dc.identifier.citedreference | Kochhar A., Zivin JA, Lyden P., Mazzarella V. ( 1988 ) Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol 45: 148 – 153. | en_US |
dc.identifier.citedreference | Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J. ( 1988 ) The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24: 543 – 551. | en_US |
dc.identifier.citedreference | Simon R., Shiraishi K. ( 1990 ) N-methyl-D-aspartate antagonist reduces stroke size and glucose metabolism. Ann Neurol 27: 606 – 611. | en_US |
dc.identifier.citedreference | Buchan A., Pulsinelli WA ( 1990 ) Hypothermia but not the N-methyl-D-aspartate antagonist, MK–801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10: 311 – 316. | en_US |
dc.identifier.citedreference | Lanier WL, Perkins WJ, Ruud B., Milde JH, Michenfelder JD ( 1990 ) The effect of dizocilipine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurological recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab 10: 252 – 261. | en_US |
dc.identifier.citedreference | Olney JW, Labruyere J., Price MT ( 1989 ) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360 – 1362. | en_US |
dc.identifier.citedreference | Olney JW, Labruyere J., Wang G., Wozniak DF, Price MT, Sesma MA ( 1991 ) NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254: 1515 – 1518. | en_US |
dc.identifier.citedreference | Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P., Honore T. ( 1990 ) 2,3-Dihydroxy–6-nitro–7-sulfamoyl-benzo (F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247: 571 – 574. | en_US |
dc.identifier.citedreference | Judge ME, Sheardown MJ, Jacobsen P., Honore T. ( 1991 ) Protection against postischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl–4-isoxazoIepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f) quinoxaline (NBQX) in the gerbil. Neurosci Lett 133: 291 – 294. | en_US |
dc.identifier.citedreference | Buchan AM, Li H., Cho S., Pulsinelli WA ( 1991 ) Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 132: 255 – 258. | en_US |
dc.identifier.citedreference | Pellegrini-Giampietro DE, Bennett MV, Zukin RS ( 1991 ) Differential expression of three glutamate receptor genes in developing rat brain: An in situ hybridization study. Proc Natl Acad Sci USA 88: 4157 – 4161. | en_US |
dc.identifier.citedreference | Rothman SM, Olney JW ( 1986 ) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105 – 111. | en_US |
dc.identifier.citedreference | Choi DW ( 1987 ) Ionic dependence of glutamate neurotoxicity. J Neurosci 7: 369 – 379. | en_US |
dc.identifier.citedreference | Uematsu D., Greenberg JH, Arali N., Reivich M. ( 1991 ) Mechanism underlying protective effect of MK-801 against NMDA-induced neuronal injury in vivo. J Cereb Blood Flow Metab 11: 779 – 785. | en_US |
dc.identifier.citedreference | Novelli A., Reilly JA, Lysko PG, Henneberry RC ( 1988 ) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451: 205 – 212. | en_US |
dc.identifier.citedreference | Beal MF ( 1992 ) Does impairment of energy metabolism result in axcitotoxic neuronal death in neurodegenerative diseases. Ann Neurol 31: 119 – 130. | en_US |
dc.identifier.citedreference | Lazarewicz JW, Wroblewski JT, Palmer ME, Costa E. ( 1988 ) Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 27: 765 – 769. | en_US |
dc.identifier.citedreference | Yu AC, Chan PH, Fishman RA ( 1986 ) Effects of arachidonic acid on glutamate and gamma-aminobutyric acid uptake in primary cultures of rat cerebral cortical astrocytes and neurons. J Neurochem 47: 1181 – 1189. | en_US |
dc.identifier.citedreference | Markwell MAK, Berger SP, Paul SM ( 1990 ) The polyamine synthesis inhibitor alpha-difluoromethylornithine blocks NMDA-induced neurotoxicity. Eur J Pharm 182: 607 – 609. | en_US |
dc.identifier.citedreference | Porcella A., Fage D., Voltz C., Carter C., Scatton B., Bartholini G. ( 1991 ) Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo. Eur J Pharm 199: 267 – 269. | en_US |
dc.identifier.citedreference | Garthwaite J., Charles SL, Chess-Williams R. ( 1988 ) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385 – 388. | en_US |
dc.identifier.citedreference | Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH ( 1991 ) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88: 6386 – 6371. | en_US |
dc.identifier.citedreference | Nowicki JP, Duval D., Poignet H. Scatton B. ( 1991 ) Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 204: 339 – 340. | en_US |
dc.identifier.citedreference | McDonald JW, Silverstein FS, Johnston MV ( 1988 ) Neurotoxicity of NMDA is markedly enhanced in developing rat central nervous system. Brain Res 459: 200 – 203. | en_US |
dc.identifier.citedreference | Ikonomidou C., Mosinger JL, Salles KS, Labruyere J., Olney JW ( 1989 ) Sensitivity of the developing rat brain to hypo-baric/ischemic damage parallels sensitivity to N-methyl-aspartate toxicity. J Neurosci 9: 2809 – 2818. | en_US |
dc.identifier.citedreference | Zaczek R., Coyle JT ( 1982 ) Excitatory amino acid analogues: Neurotoxicity and seizures. Neuropharmacology 21: 15 – 26. | en_US |
dc.identifier.citedreference | Silverstein FS, Chen R., Johnston MV ( 1986 ) The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain. Neurosci Lett 71: 13 – 18. | en_US |
dc.identifier.citedreference | Young RS, Petroff OA, Aquila WJ, Yates J. ( 1991 ) Effects of glutamate, quisqualate and N-methyl-D-aspartate in neonatal brain. Exp Neurol 111: 362 – 368. | en_US |
dc.identifier.citedreference | Tremblay E., Roisin MP, Represa A., Charriaut-Marlangue C., Ben-Ari Y. ( 1988 ) Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res 461: 393 – 396. | en_US |
dc.identifier.citedreference | McDonald JW, Johnston MV, Young AB ( 1990 ) Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp Neurol 110: 237 – 247. | en_US |
dc.identifier.citedreference | Insel TR, Miller LP, Gelhard RE ( 1990 ) The ontogeny of excitatory amino acid receptors in rat forebrain I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience 35: 31 – 43. | en_US |
dc.identifier.citedreference | Miller LP, Johnson AE, Gelhard RE, Insel TR ( 1990 ) The ontogeny of excitatory amino acid receptors in rat forebrain II. Kainic acid receptors. Neuroscience 35: 45 – 51. | en_US |
dc.identifier.citedreference | Hamon B., Heinemann U. ( 1988 ) Developmental changes in neuronal sensitivity to excitatory amino acids in area CA1 of the rat hippocampus. Brain Res 466: 286 – 290. | en_US |
dc.identifier.citedreference | Bowe MA, Nadler JV ( 1990 ) Developmental increase in the sensitivity to magnesium of NMDA receptors on CA1 hippocampal pyramidal cells. Dev Brain Res 56: 55 – 61. | en_US |
dc.identifier.citedreference | Kleckner NW, Dingledine R. ( 1991 ) Regulation of hippocampal NMDA receptors by magnesium and glycine during development. Brain Res 11: 151 – 159. | en_US |
dc.identifier.citedreference | Wasterlain CG, Hattori H., Yang C., Schwartz PH, Fujikawa DG, Morin AM, Dwyer BE ( 1990 ) Selective vulnerability of neuronal subpopulations during ontogeny reflects discrete molecular events associated with normal brain development. In: Neonatal Seizures, Wasterlain CG, Vert P., ( eds. ), pp. 69 – 81, Raven Press: New York. | en_US |
dc.identifier.citedreference | Rice JE, Vannucci RC, Brierley JB ( 1981 ) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9: 131 – 141. | en_US |
dc.identifier.citedreference | Silverstein FS, Buchanan K., Johnston MV ( 1984 ) Pathogenesis of hypoxic-ischemic brain injury in a perinatal rodent model. Neurosci Lett 49: 271 – 277. | en_US |
dc.identifier.citedreference | Silverstein FS, Buchanan K., Johnston MV ( 1986 ) Perinatal hypoxia ischemia disrupts striatal high affinity 3H-glutamate uptake into synaptosomes. J Neurochem 47: 1614 – 1619. | en_US |
dc.identifier.citedreference | Gordon KE, Simpson J., Statman D., Silverstein FS ( 1991 ) Effects of perinatal stroke on striatal amino acid efflux in rats studied with in vivo microdialysis. Stroke 22: 928 – 932. | en_US |
dc.identifier.citedreference | Hillered L., Hallstrom A., Segersvard S., Persson L., Unger-stedt U. ( 1989 ) Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab 9: 607 – 616. | en_US |
dc.identifier.citedreference | Silverstein FS, Naik B., Simpson J. ( 1991 ) Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: An in vivo microdialysis study. Pediatr Res 30: 587 – 590. | en_US |
dc.identifier.citedreference | Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA ( 1990 ) Oxidative damage to brian proteins, loss of glutamine synthase activity and production of freeradicals during ischernia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 87: 5144 – 5147. | en_US |
dc.identifier.citedreference | Johnson JW, Ascher P. ( 1987 ) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529 – 531. | en_US |
dc.identifier.citedreference | Andine P., Sandberg M., Bagenholm R., Lehmann A., Hagberg H. ( 1991 ) Intracellular and extracellular change of amino acids in the cerebral cortex of the neonatal rat during hypoxic-ischemia. Dev Brain Res 64: 115 – 120. | en_US |
dc.identifier.citedreference | Benveniste H., Jorgensen MB, Sandberg M., Christensen T., Hagberg H., Diemer NH. ( 1989 ) Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J Cereb Blood Flow Metab 9: 629 – 639. | en_US |
dc.identifier.citedreference | Globus MYT, Ginsberg MD, Dietrich WD, Busto R., Schienberg P. ( 1987 ) Substantia nigra lesion protects against ischemic damage in the striatum. Neurosci Lett 80: 251 – 256. | en_US |
dc.identifier.citedreference | Globus MYT, Busto R., Martinez E., Valdes I., Dietrich WD, Ginsberg MD ( 1991 ) Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine and gamma-aminobutyric acid in vulnerable and non-vulnerable brain regions in the rat. J Neurochem 57: 470 – 478. | en_US |
dc.identifier.citedreference | Silverstein FS, McDonald JW, Bommarito M., Johnston MV ( 1990 ) Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Stroke 21: 310 – 315. | en_US |
dc.identifier.citedreference | Ford LM, Sanberg PR, Norman AB, Fogelson MH ( 1989 ) MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch Neurol 46: 1090 – 1096. | en_US |
dc.identifier.citedreference | McDonald JW, Silverstein FS, Cardona D., Hudson C., Chen R., Johnston MV ( 1990 ) Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 36: 589 – 599. | en_US |
dc.identifier.citedreference | Olney JW, Ikonomidou C., Mosinger JL, Frierdich G. ( 1989 ) MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9: 1701 – 1704. | en_US |
dc.identifier.citedreference | Hattori H., Morin AM, Schwartz PH, Fujikawa DG, Wasterlain CG ( 1989 ) Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 39: 713 – 718. | en_US |
dc.identifier.citedreference | Chen CK, McDonald JW, Trescher WH, Johnston MV ( 1990 ) MK–801 transiently decreases cerebral temperature in perinatal rats. Soc Neurosci Abstr 16: 195. | en_US |
dc.identifier.citedreference | Hattori H., Wasterlain CG ( 1991 ) Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy. Neurology 41: 330. | en_US |
dc.identifier.citedreference | Simon RP, Young RSK, Stout S., Cheng J. ( 1986 ) Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia. Neurosci Lett 71: 361 – 364. | en_US |
dc.identifier.citedreference | Andine P., Lehmann A., Ellren K., Wennberg E., Kjellmer I., Nielsen T., Hagberg H. ( 1988 ) The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection. Neurosci Lett 90: 209 – 212. | en_US |
dc.identifier.citedreference | Prince DA, Feeser HR 1988 Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia. Neurosci Lett 85: 291 – 296. | en_US |
dc.identifier.citedreference | LeBlanc MH, Vig V., Smith B., Parker CC, Evans OB, Smith EE ( 1991 ) MK-801 does not protect against hypoxic-ischemic brain injury to piglets. Stroke 22: 1270 – 1275. | en_US |
dc.identifier.citedreference | Mosinger JL, Price MT, Bai HY, Xiao H., Wozniak DF, Olney JW ( 1991 ) Blockade of both NMDA and non-NMDA receptors is required for optimal neuroprotection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 113: 10 – 17. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.